Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients

Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients

Context: The Indian government is dispensing newer direct-acting antiviral (DAA) drugs, which may have impact on hepatitis C virus (HCV) patients’ quality of life (QoL). Aims: To evaluate different DAA regimens and impact on QoL in terms of quality-adjusted life year (QALY) in HCV patients and to me...

Full description

Bibliographic Details
Main Authors: Bhavya H Vyas, Nishita H Darji, Devang A Rana, Kaushal Y Vyas, Supriya D Malhotra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Perspectives in Clinical Research
Subjects:
hepatitis c
pharmacoeconomic
quality-adjusted life years
quality of life
Online Access:http://www.picronline.org/article.asp?issn=2229-3485;year=2021;volume=12;issue=2;spage=76;epage=82;aulast=Vyas

Internet

http://www.picronline.org/article.asp?issn=2229-3485;year=2021;volume=12;issue=2;spage=76;epage=82;aulast=Vyas

Similar Items